Psychosis Mental and Behavioural Disorders
Conditions
Interventions
This trial is a pilot randomised controlled study recruiting patients attending an early intervention for psychosis service in Ireland. The trial explores the feasibility, acceptability, and effective
Sponsors
Ollscoil na Gaillimhe – University of Galway
Eligibility
Sex/Gender
All
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: 1. Aged between 18 and 35 years old 2. Clinically stable and having the ability to give consent 3. Self-reporting mental health difficulties of longer than one year in duration
Exclusion criteria
Exclusion criteria: 1. History of organic impairment (including IQ 5-minute duration 2. Drug or alcohol dependent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Feasibility outcomes: Rates of recruitment and retention measured using data recorded in patient records at baseline, 3 months (12 weeks) and 6 months (26 weeks) | — |
Secondary
| Measure | Time frame |
|---|---|
| The following secondary outcome measures will be measured during interviews with the participant at baseline, 3 months (12 weeks) and 6 months (26 weeks): Demographic/Clinical measures: 1. Data on age, sex, living situation, educational experience, and employment history measured using and assessment Interview 2. Drug use measured using the Drug Use Disorders Identification Test (DUDIT) 3. Alcohol use measured using the Alcohol Use Disorders Identification Test (AUDIT) 4. Severity of positive and negative symptoms in psychosis measured using the Scale for the Assessment of Positive Symptoms (SAPS) and the Scale for the Assessment of Negative Symptoms (SANS) 5. Anxiety symptoms measured using the Generalized Anxiety Disorder Assessment (GAD-7) 6. Depressive symptoms measured using the Patient Health Questionnaire (PHQ-9) 7. Self-care capability measured using the Independent Living Scale 8. Time spent on various daily activities measured using the Time Use Survey 9. Social and occupational functions measured using the Social and Occupational Functioning Assessment Scale (SOFAS) 10. Social and occupational function measured using the Global Assessment of Functioning (GAF) 11. Occupational functioning, social functioning, and symptom severity measured using the Mental Illness Research, Education, and the Clinical Center version of the Global Assessment of Functioning (MIRECC GAF) 12. Loneliness measured using the UCLA Loneliness Scale Cognition measures: 1. Theory of mind measured using Reading the Eyes in the Mind 2. Emotion recognition measured using the Cambridge Neuropsychological Test Automated Battery - Emotional Recognition Task (CANTAB ERT) 3. General cognitive ability prior to illness measured using the Test of Premorbid Functioning (TOPF) 4. Verbal episodic memory measured using the Weschler Memory Scale (WMS) Logical Memory Test 5. Visuospatial abstract reasoning measured using the Weschler Matrix Reasoning 6. Verbal abstract reasoning measured using the W | — |
Countries
Ireland
Contacts
Public ContactGary Donohoe
Outcome results
None listed